1453 related articles for article (PubMed ID: 19671963)
41. Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin.
Cao Y; Gu Y; Ma H; Bai J; Liu L; Zhao P; He H
Int J Biol Macromol; 2010 Mar; 46(2):245-9. PubMed ID: 19958788
[TBL] [Abstract][Full Text] [Related]
42. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
44. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer.
Wang Y; Gao S; Ye WH; Yoon HS; Yang YY
Nat Mater; 2006 Oct; 5(10):791-6. PubMed ID: 16998471
[TBL] [Abstract][Full Text] [Related]
45. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation.
Shah M; Ullah N; Choi MH; Kim MO; Yoon SC
Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562
[TBL] [Abstract][Full Text] [Related]
46. Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery.
Wang Y; Jiang G; Qiu T; Ding F
Drug Dev Ind Pharm; 2012 Sep; 38(9):1039-46. PubMed ID: 22124381
[TBL] [Abstract][Full Text] [Related]
47. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
48. Functionalized amphiphilic hyperbranched polymers for targeted drug delivery.
Chen S; Zhang XZ; Cheng SX; Zhuo RX; Gu ZW
Biomacromolecules; 2008 Oct; 9(10):2578-85. PubMed ID: 18665638
[TBL] [Abstract][Full Text] [Related]
49. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
50. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
Lee AL; Wang Y; Cheng HY; Pervaiz S; Yang YY
Biomaterials; 2009 Feb; 30(5):919-27. PubMed ID: 19042015
[TBL] [Abstract][Full Text] [Related]
51. Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles.
López-Gasco P; Iglesias I; Benedí J; Lozano R; Blanco MD
Anticancer Drugs; 2012 Oct; 23(9):947-58. PubMed ID: 22713593
[TBL] [Abstract][Full Text] [Related]
52. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.
Zhu A; Yuan L; Jin W; Dai S; Wang Q; Xue Z; Qin A
Acta Biomater; 2009 Jun; 5(5):1489-98. PubMed ID: 19286431
[TBL] [Abstract][Full Text] [Related]
53. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
54. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
[TBL] [Abstract][Full Text] [Related]
55. Nanoformulation of paclitaxel to enhance cancer therapy.
Gu Q; Xing JZ; Huang M; Zhang X; Chen J
J Biomater Appl; 2013 Aug; 28(2):298-307. PubMed ID: 22561979
[TBL] [Abstract][Full Text] [Related]
56. Encapsulated plant extract (Gelsemium sempervirens) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro.
Bhattacharyya SS; Paul S; Khuda-Bukhsh AR
Exp Biol Med (Maywood); 2010 Jun; 235(6):678-88. PubMed ID: 20511672
[TBL] [Abstract][Full Text] [Related]
57. Multifunctional pluronic/poly(ethylenimine) nanoparticles for anticancer drug.
Li N; Yang X; Zhai G; Li L
J Colloid Interface Sci; 2010 Oct; 350(1):117-25. PubMed ID: 20598703
[TBL] [Abstract][Full Text] [Related]
58. Isolation, purification and characterization of silk protein sericin from cocoon peduncles of tropical tasar silkworm, Antheraea mylitta.
Dash R; Mukherjee S; Kundu SC
Int J Biol Macromol; 2006 May; 38(3-5):255-8. PubMed ID: 16620954
[TBL] [Abstract][Full Text] [Related]
59. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
60. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
Subia B; Kundu SC
Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]